Bionanotechnology News

RSS

Researchers Use Liposomes to Effectively Deliver Powerful Anti-Cancer Compound

Researchers at the University of California, San Diego School of Medicine have discovered a way to effectively deliver staurosporine (STS), a powerful anti-cancer compound that has vexed researchers for more than 30 years due to its instability in the blood and toxic nature in both healthy and cancerous cells.

23 Oct 2013

Anasys nanoIR Technology Used to Study Photosynthesis

Anasys Instruments reports on EPFL's publication in Plant Cell on the use of nanoIR to look into the process of photosynthesis to shed more light on how plants produce energy.

22 Oct 2013

Nanosight's Nanoparticle Tracking Analysis Used to Demonstrate Performance of BD Medical's Silicone Coating

NanoSight reports on how Nanoparticle Tracking Analysis, NTA, has been used to demonstrate the product performance of BD Medical - Pharmaceutical Systems' novel cross-linked silicone coating, BD XSi™, used in BD's prefillable syringe BD Neopak XSi™.

22 Oct 2013

Genetic Code Completely Changed Across an Organism’s Genome

Scientists from Yale and Harvard have recoded the entire genome of an organism and improved a bacterium’s ability to resist viruses, a dramatic demonstration of the potential of rewriting an organism’s genetic code.

19 Oct 2013

Study of structure and dynamics of biological membranes reported by JPK

JPK reports on the study of structure and dynamics of biological membranes using AFM and advanced fluorescence microscopies in Pierre-Emmanuel Milhiet's group at the CBS in Montpellier Berlin, 15th October 2013: J...

15 Oct 2013

Novel Nanoparticle-Based Smart Hydrogel Holds Promise for Cartilage Regeneration

A team of EPFL scientists has developed a smart hydrogel material that could promote cartilage regeneration. Their method consists in releasing medication at the right place and at the right time. In the future, damage to cartilage following injuries may no longer have to be irreversible.

15 Oct 2013

UK-Based Oxford Nanopore Technologies Raises £40 Million in New Funding

Oxford Nanopore Technologies Ltd, the UK-based technology company specialising in nanopore-based electronic molecular analysis systems, has raised £40 million in new funding through a private placement of ordinary shares. The investment was received from new and existing investors in the US, UK and mainland Europe. New investors include Odey Asset Management.

From Oxford Nanopore Technologies Ltd 10 Oct 2013

New Investment for Development of CNSE’s RNA Technology by Hocus Locus

Governor Andrew M. Cuomo today announced that the RNA technology invented at CNSE will be developed by Albany-based Hocus Locus, LLC with a recent investment from Eastern New York Angels. Once developed, the technology will provide medical researchers and healthcare providers with a new diagnostic tool to aid in the detection of cancer and other diseases. Its creators say the technology could also lead to the development of new treatments for those diseases.

From College of Nanoscale Science and Engineering, University at Albany 10 Oct 2013

NIH Grant to Develop New Nanotechnology for Better Cancer Treatment

UB researcher Jonathan Lovell has received a five-year, $1.9 million grant from the National Institutes of Health to work on a new nanotechnology that could greatly improve how doctors treat and understand cancer.

5 Oct 2013